# Evaluation of the Effects of Duloxetine on Norepinephrine

> **NCT00414323** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 35 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Duloxetine
- **DRUG:** Escitalopram
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00414323
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2007-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00414323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00414323, "Evaluation of the Effects of Duloxetine on Norepinephrine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00414323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*